Dual system for the central nervous system targeting and blood‐brain barrier transport of a selective prolyl oligopeptidase inhibitor
- 26 July 2013
- journal article
- research article
- Published by Wiley in Peptide Science
- Vol. 100 (6) , 662-674
Abstract
Less than 2% of all potential neurotherapeutics cross the blood‐brain barrier (BBB). Here, we sought to build a construct with the capacity to cross this barrier, to behave as a chemical delivery system, and, once inside the central nervous system, to be transformed and then act as an enzyme inhibitor. With all this in mind, here, we describe the entire process to obtain such a compound, from the initial candidate selection to preparation of the compound library and posterior evaluation and final selection of the most promising candidates in terms of selectivity, serum stability, and BBB‐transport. © 2013 Wiley Periodicals, Inc. Biopolymers (Pept Sci) 100: 662–674, 2013.Keywords
This publication has 48 references indexed in Scilit:
- Inhibition of dipeptidyl peptidase IV (DPP IV) is one of the mechanisms explaining the hypoglycemic effect of berberineJournal of Enzyme Inhibition and Medicinal Chemistry, 2009
- Type 2 diabetes mellitus: epidemiology, pathophysiology, unmet needs and therapeutical perspectivesDiabetes & Metabolism, 2007
- Psychotropic Profile of S 17092, a Prolyl Endopeptidase Inhibitor, Using Quantitative EEG in Young Healthy VolunteersNeuropsychobiology, 2007
- 3D-QSAR studies of Dipeptidyl peptidase IV inhibitors using a docking based alignmentJournal of Molecular Modeling, 2007
- Dipeptidyl peptidase 4 inhibition and vildagliptin therapy for type 2 diabetesInternational Journal Of Clinical Practice, 2007
- Pharmacodynamic and pharmacokinetic profile of S 17092, a new orally active prolyl endopeptidase inhibitor, in elderly healthy volunteers. A phase I studyBritish Journal of Clinical Pharmacology, 2000
- Site-Selective N-Methylation of Peptides on Solid SupportJournal of the American Chemical Society, 1997
- Brain-Targeted Delivery of a Leucine-enkephalin Analogue by Retrometabolic DesignJournal of Medicinal Chemistry, 1996
- Improved delivery through biological membranes. 32. Synthesis and biological activity of brain-targeted delivery systems for various estradiol derivativesJournal of Medicinal Chemistry, 1988
- FINE STRUCTURAL LOCALIZATION OF A BLOOD-BRAIN BARRIER TO EXOGENOUS PEROXIDASEJournal of Cell Biology, 1967